Weiwei Cui
Impact in
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 4
- RNA modifications and cancer 2
-
- Ferroptosis and cancer prognosis 4
- Co-authors
- Bo Chu (5 shared papers)Wei Gu (2 shared papers)Dong Liu (2 shared papers)Xiaoju Zhang (1 shared paper)Yudan Zhang (1 shared paper)Li Yang (1 shared paper)Yinghong Yang (1 shared paper)Xiao Zhuang (1 shared paper)
- Journals
- Advanced Science (2 papers)Molecular Cancer Research (2 papers)Molecular Carcinogenesis (2 papers)Journal of Pharmacy and Pharmacology (1 paper)Cell Death and Differentiation (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weiwei Cui
13 papers receiving 381 citations
Weiwei Cui's Hit Papers
Peers
Comparison fields: 5 of 63
- Cancer Research 146
- Biological Psychiatry 17
- Pulmonary and Respiratory Medicine 192
- Molecular Biology 208
- Biochemistry 14
Countries citing papers authored by Weiwei Cui
This map shows the geographic impact of Weiwei Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Cui more than expected).
Fields of papers citing papers by Weiwei Cui
This network shows the impact of papers produced by Weiwei Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Cui. The network helps show where Weiwei Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 167 | |
| 2 | Tryptophan Metabolism Acts as a New Anti‐Ferroptotic Pathway to Mediate Tumor Growth Hit paper breakdown → | 2023 | 110 |
| 3 | 2025 | 19 | |
| 4 | 2023 | 16 | |
| 5 | 2024 | 16 | |
| 6 | 2019 | 14 | |
| 7 | 2017 | 13 | |
| 8 | 2021 | 13 | |
| 9 | 2019 | 5 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 3 | |
| 12 | 2022 | 2 | |
| 13 | 2024 | 1 |
About Weiwei Cui
Weiwei Cui is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Obstetrics and Gynecology, having authored 13 papers that have together received 384 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer, Lipids, and Metabolism (2 papers), Pregnancy and preeclampsia studies (2 papers), RNA modifications and cancer (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Endometriosis Research and Treatment (1 paper) and Clusterin in disease pathology (1 paper). The work is most often cited by research in Cancer Research (146 citations), Biological Psychiatry (17 citations), Pulmonary and Respiratory Medicine (192 citations), Molecular Biology (208 citations) and Biochemistry (14 citations). Weiwei Cui has collaborated with scholars based in China and United States. Frequent co-authors include Bo Chu, Wei Gu, Dong Liu, Xiaoju Zhang, Yudan Zhang, Li Yang, Yinghong Yang, Xiao Zhuang, Lutao Du and Bin Huang. Their work appears in journals such as Advanced Science, Molecular Cancer Research, Molecular Carcinogenesis, Journal of Pharmacy and Pharmacology and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.